Introduction/Background {#S1}
=======================

Chromatin Remodeling {#S1.SS1}
--------------------

Eukaryotic cells package their genomic DNA into chromatin. The basic unit of chromatin, the nucleosome, consists of a histone octamer of four core histones: H2A, H2B, H3, and H4 ([@B90]). Histone variants are able to substitute for the core canonical histones within the nucleosomes and often confer specific structural and functional features ([@B68]). Additional factors, such as linker histones, further organize nucleosomes into higher-order chromatin structures ([@B54]). Chromatin ultimately needs to be remodeled for DNA transactions such as transcription to occur ([@B33]). Mechanisms of chromatin remodeling (CR) involve ATP-dependent histone sliding \[e.g., SWI/SNF ([@B76]), INO80 ([@B110]), and ISWI ([@B154])\] and the selective insertion/removal of histone variants \[SWR ([@B97]) and INO80 ([@B21])\], as well as the post-translational modification ([@B56]) (PTM) of specific amino acids within histones including lysine acetylation and methylation. Histone PTMs can lead to downstream events via recruitment of proteins with specific PTM-interacting domains including the bromodomain (BRD) that interacts with acetylated lysines ([@B50]).

The Histone Acetylation Cycle and Its Relevance to Human Disease {#S1.SS2}
----------------------------------------------------------------

The histone acetylation cycle begins with the selective addition of an acetyl group to a specific lysine residue in histones, a process known as histone acetylation, and is catalyzed, or "written," by histone acetyltransferases \[HATs ([@B20])\]. HATs can be guided to their specific histone targets by physically interacting with proteins containing histone-interacting domains ([@B83]). Bromodomain proteins are able to interact, or "read" acetyl-lysine (Kac), and the cycle is complete when the acetyl is removed, or "erased," by histone deacetylases (HDACs) ([@B82]). Histone acetylation occurs either at the nucleosomal level by type A HATs \[SAGA ([@B18]) and NuA4 ([@B43]) complexes\] or on histones prior to their deposition into chromatin by type B HATs \[Hat1 ([@B107]), Rtt109 ([@B51])\]. Although the focus of this review is histone acetylation, it is important to note that proteomic studies have identified hundreds to thousands of acetylated proteins in a variety of model systems from parasitic protozoa to mammalian cells ([@B161]; [@B74]; [@B95]; [@B86]). To reflect this, HATs and HDACs that acetylate/deacetylate the group of lysine residues on non-histone substrates are also be referred to as lysine acetyltransferases/deacetylases (KATs/KDACs) ([@B4]).

The proteins of the histone acetylation cycle have clinical significance in cancer ([@B128]; [@B71]; [@B114]) and have attracted interest as potential druggable targets. For example, translocation of BRD-containing BRD4 to NUTM1 in human cells generates an oncoprotein that drives a rare and aggressive form of squamous cell carcinoma, NUT midline carcinoma (NMC) ([@B53]). Multiple small molecules have been developed that disrupt BRD-Kac interactions ([@B34]) and are subject of investigation for their efficacy in treating cancers such as NMC. HATs, BRDs, and HDACs are often required for the viability and pathogenesis of parasitic protozoa ([@B75]) which are among the Neglected Tropical Diseases (NTD) common in regions of Africa, Asia, and the Americas ([@B151]). Anti-protozoa drugs exist but their efficacy is being compromised by rising resistance ([@B41]). The availability of small molecule inhibitors to proteins of the histone acetylation cycle has driven interest in their use to treat these diseases. The Alveolate lineage of eukaryotes includes the parasitic apicomplexa, with *Plasmodium* and *Toxoplasma* species. Gcn5 was shown to be essential for *Toxoplasma* DNA replication, prompting a search for drugs that target this HAT ([@B138]; [@B73]). In *Plasmodium*, PfBDP1 containing a C-terminal BRD and an N-terminal ankyrin repeat is required for penetration of red blood cells ([@B77]), potentially providing a drug target. Plasmodium HDACs are also being investigated as possible drug targets ([@B14]).

*Tetrahymena thermophila* as a Model for the Study of the Histone Acetylation Cycle {#S1.SS3}
-----------------------------------------------------------------------------------

The ciliate *Tetrahymena thermophila* (Tt), a free-living genetically tractable Alveolate, has been a beneficial model for early studies of the fundamental biology of histone acetylation due to its unique nuclear biology ([@B64]). Tt is suitable to study apicomplexan biology as well as that of other protozoan parasites due to their evolutionary relationship. Tt is also a proven model for discovery-based chromatin biology, based in part on the biology of the ciliates, which segregate germline-specific silent, and somatic transcriptionally active chromatin into two distinct nuclei ([@B103]). The micronucleus (MIC) is diploid, divides by mitosis, and is not transcribed during growth. The MIC undergoes meiosis during conjugation, the sexual phase of the life cycle, and is analogous to a germline nucleus. The macronucleus (MAC) is highly polyploid with ∼45 copies of each MAC chromosome, divides amitotically without functional centromeres, is transcriptionally active, and is not inherited sexually; analogous to a somatic nucleus. During amitosis, multiple copies of each macronuclear chromosome are randomly partitioned between the two daughter cells. As a result, alleles segregate randomly, and therefore vegetative progeny of a cell initially heterozygous after conjugation become homozygous for one of the alleles after a number of cell divisions in a process called phenotypic assortment ([@B104]). The two nuclei are related to each other through the sexual life cycle, conjugation ([@B91]), the milestones of which are shown in [Figure 1](#F1){ref-type="fig"}. MAC development includes a variety of programmed DNA rearrangements that includes chromosome fragmentation, and programmed deletion of DNA sequence called internal eliminated sequences (IESs) which is epigenetically regulated in a process that is initiated by genome-wide transcription of non-coding RNAs ([@B27]) (ncRNAs) from the normally silent MIC. The ncRNAs then direct RNAi-dependent assembly of distinct chromatin domains in the new MAC ([@B132]; [@B89]), a prelude to DNA deletion ([@B156]) thought to be similar to the chromatin diminution seen in the parasitic nematode Ascaris ([@B144]).

![Life cycle of *Tetrahymena thermophila* (Tt). Parental macronuclei are shown in orange. After pairing of two cells of different mating types, the respective MICs (shown in blue and yellow) undergo meiosis. In each cell, one of the four meiotic products is selected as the nucleus that will be inherited, and the other three degenerate. The selected meiotic product in each cell undergoes mitosis to produce two identical pro-nuclei, one of which is transferred to the mating partner where they fuse to form a zygotic nucleus that further divides mitotically twice to generate four nuclei (shown now in green), two of which will develop as new MACs, and two as MICs. As the new MACs are developing, the parental MAC condenses and degenerates. Time periods shown correspond to hours post mixing of the two cells.](fcell-08-00509-g001){#F1}

*Tetrahymena thermophila* has features of a model genetic organism including fast growth in axenic culture, and the ability to undergo large scale and synchronous matings. Both the MAC ([@B48]) and MIC ([@B66]) genomes have been sequenced and annotated ([@B130]). A well-developed functional proteomic pipeline exists for the study of epigenetic regulators in particular for **a**ffinity **p**urification coupled to **m**ass **s**pectrometry (AP-MS) to effectively solubilize native (i.e., un-crosslinked) protein complexes both bound and unbound to chromatin ([@B153]; [@B57], [@B58]; [@B117], [@B118]; [@B16]; [@B98]). A critical feature of this approach is the expression of the epitope tagged proteins at levels closely approximating that of the endogenous protein. In *Tetrahymena* this is achieved by exact gene replacement mediated by homologous recombination, adding the epitope tag in-frame at the C-terminus of the endogenous protein, such that the epitope tagged polypeptide is expressed under its own promoter, as in budding yeast. Physical Interactome mapping experiments are performed using a minimum of two biological replicates in parallel to control experiments using untagged parental strains, facilitating the identification of interaction partners significantly over-represented in the samples, a process aided by use of algorithms such as SAINTexpress ([@B134]). Functional genomic approaches that have been developed for Tt include definition of the transcriptome through microarray ([@B96]) and RNA-Seq analysis ([@B153]). Because Tt gene expression can be assessed in a variety of developmental stages, network analysis of transcriptome data can be used to predict functional relationships between genes ([@B153]). In addition, genomic localization of proteins involved in the acetylation cycle can be tracked using ChIP-Seq (**ch**romatin **i**mmuno**p**recipitation followed by next generation **seq**uencing) ([@B117], [@B119]).

Histone Acetylation in *Tetrahymena thermophila* {#S2}
================================================

In addition to their distinct morphologies and functions, differences exist in the complement of chromatin proteins as well as the degree of histone acetylation in the MAC and MIC. Although the same core histones (H2A, H2B, H3, and H4) are present in both nuclei, the MIC possesses two versions of histone H3 ([@B8]). One of which is indistinguishable from that found in the MAC (named H3S for slow), and the other is unique to MIC, and has a faster mobility in SDS-PAGE (and thus named H3F for fast) as a consequence of a regulated proteolytic event where six amino acids are removed from the N-terminus ([@B5]; [Figure 2A](#F2){ref-type="fig"}); the underlying enzymology of which is unknown. Nucleus-specific linker histones exist, Hho1 for the MAC and Mlh1 (Micronuclear linker histone 1) for the MIC. Mlh1 in particular is proteolyzed ([@B3]) into several smaller polypeptides (alpha, beta, gamma, and delta). Although HHO and MLH are non-essential genes, DAPI staining combined with knockout analysis showed that both function in the condensation of chromatin in their respective nuclei ([@B123]). The MIC also features the exclusive localization of CNA1 ([@B26]; [@B36]), an ortholog of the centromeric-specific H3 variant CENPA, consistent with apparent lack of centromeres in the MAC. Transcription associated histone variants Hv1 (H2A.Z) and Hv2 (H3.3) are MAC-specific ([@B7]) during growth and starvation, appearing in the MIC only during selected times in conjugation ([@B129]; [@B37]). In addition to being widely distributed in the MAC by immunofluorescence (IF), Hv1 localizes to the nucleoli indicating that it may be involved in rDNA transcription ([@B12]). The use of specific anti-Hv1 antibodies in indirect IF indicates that Hv1 may present in the crescent MIC, a time when it is transcriptionally active ([@B129]). Hv2 differs in 16 amino acids from the major, abundant H3 proteins and is expressed constitutively ([@B135]). Genetic analysis suggests that the primary importance of HHT3 in growing cells is a consequence of its constitutive expression rather than its primary sequence ([@B157]).

![Multiple sequence alignment of histone N-termini. Clustal Omega was used to perform multiple sequence alignment (EMBL-EBI) and shaded using BoxShade (ExPASy). Absolutely conserved residues are represented by a black shade and conserved residues are represented by a gray shade. Red circles represent sites of acetylation as indicated in the text. **(A)** N-termini of histone H3. The arrow indicates site of N-terminal proteolysis. **(B)** N-termini of histone H4. **(C)** N-termini of histone H2A variant Hv1/H2AZ. Tt, *Tetrahymena thermophila*; Hs, *homo sapiens*; Sc, *Saccharomyces cerevisiae*.](fcell-08-00509-g002){#F2}

Some of the earliest observations linking histone acetylation and transcription occurred using the Tt model. Pulse-labeling studies using radiolabeled acetate was used to show that histones in general are highly acetylated in the MAC but not MIC in growing cells ([@B139], [@B140]), a finding that provided a key functional link of histone acetylation to gene expression. Initial studies on histone deposition-associated acetylation focused on pulse-labeling cells with radiolabeled acetate early in conjugation where MICs replicate rapidly, but are transcriptionally inactive, thus any MIC-specific histone acetylation at this time is related functionally to histone deposition and chromatin assembly. Initial studies showed that newly synthesized histone H3 and histone H4 were deposited into MIC in mono- and di-acetylated (H3) and di-acetylated (H4) forms ([@B6]). Later work identified these deposition-associated acetylation sites on K9/14 on H3 ([@B127]; [Figure 2A](#F2){ref-type="fig"}) and H4 K4/11 ([@B30]; [Figure 2B](#F2){ref-type="fig"}, note corresponds to H4K5/12 in yeast and human cells: Tt H4 contains a single deletion at amino acid 3, so each acetylation site is numbered one less than that observed in most other H4s). Similar studies on pulse-labeled MACs isolated during growth revealed H4K7 ([Figure 2B](#F2){ref-type="fig"}, corresponds to H4K8) and H4K4 to be the principle sites of acetylation correlated with transcription on H4, with H4K11 and H4K15 also acetylated at lower levels ([@B30]; [Figure 2A](#F2){ref-type="fig"}). Transcription-associated sites of acetylation on H3 were revealed to be H3K9 and H3K14 and to a lesser extent H3K18 and H3K23 ([@B30]; [Figure 2B](#F2){ref-type="fig"}). Subsequent studies found Hv1 to be acetylated at positions 4, 7, 10, 13, 16 in its N-terminus ([@B10]; [Figure 2C](#F2){ref-type="fig"}). When indirect IF was performed with newly developed anti-tetra-acetylated H4 and anti-penta acetylated Hv1 antibodies, MAC localization was observed ([@B88]). When studying the extent of histone acetylation during conjugation, only a slight increase in acetylation was shown in the early developing new MACs compared to the developing micronuclei at the same stage. A greater amount of acetylation is detected in the advanced stage of anlagen development comparable to the parental macronuclei ([@B28]) suggesting that there is modulation of the histone acetylation cycle during nuclear development.

Histone Acetyl-Transferases in *Tetrahymena thermophila* {#S3}
========================================================

Histone acetyltransferases are responsible for catalyzing the transfer of acetyl groups from acetyl-CoA onto lysine residues on the amino-termini of histones. There are five genes that encode clear orthologs of HATs \[*GCN5/HAT2*, *HAT1*, and 3 MYST-family HATs (*MYST1-3*)\].

Gcn5/SAGA {#S3.SS1}
---------

The search for the gene encoding a HATs was hampered by relatively low amounts of the enzyme that made it difficult to obtain peptide sequence. For example a HAT activity was identified and characterized in yeast in the early 1980s ([@B137]), but the gene responsible was not cloned ([@B101]). The massive amount of acetylated chromatin in the Tt MAC was key to finding the first gene encoding a HATs. A novel SDS-PAGE acetyltransferase activity assay was used to show that the Tt MAC possess a 55 kDa protein (p55) able to incorporate \[3H\] acetate from \[3H\] acetyl-coA into a histone H3 substrate ([@B22]). After partial purification using the in gel-assay to monitor the activity, Edman degradation and subsequent molecular cloning followed by comparative sequence analysis determined that p55 is orthologous to Gcn5 ([@B23]), a transcriptional adaptor, or co-activator previously described as necessary for activity of transcriptional activators in yeast ([@B59]). This finding established the mechanistic link between chromatin structure and gene expression, and reinforced the idea of histone acetylation as a mark of transcriptionally active chromatin. Gcn5 is broadly conserved in eukaryotes present in most if not all sequenced eukaryotes including *Toxoplasma gondii* ([@B143]) and *Plasmodium falciparum* ([@B49]). In yeast and human cells, Gcn5 is found in the multi-subunit complex SAGA ([@B60]), a transcriptional co-activator complex containing ∼19 subunits ([@B2]; [@B39]) that, as a type A HAT, targets the nucleosomal N-terminal tail of H3 ([@B60], [@B62], [@B61]). The original type A HAT, Gcn5p, may also possess type B HAT activity in *Saccharomyces cerevisiae* as it is involved in the acetylation of the NH2-terminal tail of newly synthesized histone H3 ([@B24]).

Details on the function and mechanism of Tt Gcn5 have lagged since its initial discovery. Recombinant Tt Gcn5 acetylates free histone H3 including on H3K13 and H3K18 ([@B57]; [Figure 2A](#F2){ref-type="fig"}). The questions as to the nature of Tt SAGA was recently addressed ([@B117]) by AP-MS of Ibd1 (see section "Group II BRD Proteins," below) that revealed p55/Gcn5 to be present in a complex with a clear ortholog of Ada2, as well as the BRD-containing Ibd1, and PHD-domain containing protein **[A]{.ul}**da2-**A**ssociated **P**rotein **[1]{.ul}** (AAP1). One function of PHD domains is to interact with methyl-lysine PTMs ([@B15]). Subsequent AP-MS of Ada2 reciprocally identified Gcn5, Ibd1, Aap1 and three additional PHD domain-containing proteins (Aap2-4) that were not observed in repeated Ibd1 AP-MS. Consistent with this, a SAGA-like complex consisting of orthologs of Gcn5, Ada2, and a PHD domain protein (PHD1) in addition to a protein of unknown function, was purified from Apicomplexan *P. falciparum* by incubation of extracts with a biotinylated H3K4me3 peptide ([@B69]). The same complex minus the protein of unknown function co-purified when extracts were incubated with an H4K5/8/12ac peptide. Additionally, AP-MS of PfGcn5 revealed an interaction with an additional PHD-domain-containing protein PHD2, purification of which enriched Gcn5 and Ada2 but not PHD1. The similarities between Gcn5 membership in multiple protein complexes in Tt and Pf suggest that multiple SAGA-like complexes exist in Alveolates that are composed of a "core" of Ada2 and Gcn5 with different epigenetic readers that in Tt and Pf are composed of PHD and BRD proteins. To demonstrate this conclusively, AP-MS of Tt Aap2-4 will be required, the prediction being that each will co-purify with Ada2 and Gcn5 but none of the other readers. If this is the case, it will be important to determine chromatin-binding specificity of the respective PHD fingers of the AAPs. BLASTP analysis indicates that AAP1 is the highest match in the Tt genome of Pf PHD1 with high homology between the two in their fourth PHD domain of PHD1 that matches consensus for H3K4me2/3-binding.

Hat1 {#S3.SS2}
----

Hat1 was originally purified from yeast cytoplasmic extracts in a complex with Hat2 (Rbap46 in mammalian cells). Hat1 is a type B HAT, highly specific for H4K5 and H4K12 on free histones in yeast and humans ([@B107]). Tt encodes a clear ortholog of *HAT1*, but to date it has not been subjected to molecular analysis. Experiments performed by Allis and colleagues showed MIC and cytoplasmic extracts of growing Tt to possess a HAT activity on Tt H4 ([@B113]) that had specificity for position 4 or positions 4 and 11 ([@B113]; [Figure 2B](#F2){ref-type="fig"}, the sites that correspond to H4K5/12 in Tt). The same activity did not acetylate mononucleosomes, consistent with Hat1 activity in yeast and human cells ([@B109]; [@B141]). Based on work performed in yeast and human cells, it would make sense that this activity was performed by the Hat1 complex ([@B109]), composed of the Hat1 HAT bound to the Hat2/RbAp46 histone chaperone ([@B108]). The expression of HAT1 is essential in human cells ([@B99]). Interestingly, when the cytoplasmic activity was heated to 45°C, the Hat1-like activity on H4 was retained, but now the activity also mono-acetylated H3 at an unknown lysine residue ([@B113]). It will informative to characterize the Hat1 complex in Tt and to determine whether it has activity on H3 as well as H4.

NuA4/Esa1 {#S3.SS3}
---------

NuA4/TIP60 are multi-subunit type A HAT complexes in yeast and human cells responsible for acetylation of nucleosomal histone H4 and H2A with catalytic subunit Esa1/Tip60 ([@B43]; [@B70]). Analogous H2A/H4-specific Hat A activities are more poorly characterized outside the Opisthokonts. In Tt, a H2A/H4-specific nucleosomal HAT activity was previously partially purified from MAC DNAse-treated extracts, and labeled NuA4-like ([@B102]). Yeast/human NuA4/TIP60 complexes and the Tt NuA4-like activity both have specificity for lysines 5, 8, 12, and 16 of H4 and lysines 5 and 9 of H2A on nucleosomes ([@B102]), suggesting the activity could be catalyzed by an analogous Tt complex. However, the Tt NuA4-like activity co-purified on a sucrose gradient with a predicted size of ∼ 80 kD which is much smaller than that of NuA4/TIP60 complex, a 1.0--1.5 MDa multi-protein platform of at least 13--16 subunits. Comparative sequence analysis of the MAC genome suggests that there are three potential Tt genes encoding an ortholog of Esa1/Tip60, named MYST1-3, with MYST1 and MYST2 situated side by side in the MAC genome, possibly the result of a tandem duplication. Yeast also encode three MYST family HATs, each of which nucleates a distinct HAT complex with non-overlapping functions (Esa1-NuA4, Sas2 -- SAS complex and Sas3 of the NuA3 complex). The parasitic protozoa *Trypanosoma brucei* (*T. brucei*) encodes three MYST family proteins named HAT1-3 that all localize to its nucleus ([@B78]). *P. falciparum* encodes a single gene encoding a MYST family HAT ([@B94]). Clear orthologs of genes encoding core NuA4/Tip60 proteins Eaf1 and Epl1 are not present in the Tt MAC genome or that of other Alveolates, consistent with the idea that a NuA4 complex is not well conserved outside the Opisthokonts. Identification of the Tt MYST HAT underlying the NuA4-like activity, and identification of co-purifying proteins, is likely to inform NuA4/TIP60 characterization in the parasitic protozoa.

H3K56 Acetylation in *Tetrahymena thermophila* {#S3.SS4}
----------------------------------------------

H3K56ac is associated with DNA replication associated chromatin assembly, gene expression, and maintenance of genome stability in yeast and human cells ([@B93]; [@B40]). H3K56 is conserved in Tt H3 ([Figure 2A](#F2){ref-type="fig"}), and the MAC possesses robust levels of H3K56ac during growth ([@B55]) and early nuclear development ([@B1]). Although not widely studied outside of Fungi and human cells, H3K56ac has been reported to be present in parasitic protozoa such as *P. falciparum* ([@B65]). H3K56ac is catalyzed by Rtt109 in Fungi ([@B35]; [@B45]; [@B51]) and p300/CBP in humans ([@B40]). In Fungi and human cells, histone H3/H4 chaperone ASF1 is also required to catalyze H3K56ac ([@B111]; [@B40]) by the respective HAT. Tt does not encode a clear ortholog of either Rtt109 or p300/CBP but does encode a single copy of *ASF1* ([@B57]). Rtt109 has drawn recent interest as a possible drug target to combat pathogenic fungal infection due to its fungal-specific nature and importance to viability ([@B152]). Despite their non-homologous primary amino acid sequence, Rtt109 and p300/CBP have structural similarity of their catalytic core ([@B19]). Human Gcn5 has been reported to acetylate H3K56 in human cells ([@B136]), but not in yeast. Recombinant Tt p55/Gcn5 does not possess H3K56ac activity *in vitro* on core histone substrates in the presence or absence of recombinant yeast or Tt Asf1 ([@B57]) which argues against Gcn5 being the H3K56-specific HAT in Tt. It should be noted that the HAT assay was performed with chicken and not Tt histones, and that in Tt Gcn5 exists in a protein complex with an Ada2 ortholog (see section "Gcn5/SAGA"), so its behavior *in vitro* may reflect absence of key components. Functionally, the importance of the modification to growth/genome stability in Tt has yet to be determined, or even if it is linked to chromatin assembly as in yeast. Arabidopsis have also been demonstrated to encode orthologs of p300/CBP suggesting that p300/CBP was present in last common ancestor of plants and Opisthokonts, which should also include protist lineages. If H3K56ac is important to protozoan viability, the H3K56-specific HAT (particularly if novel) may have potential as a drug target for treatment of parasitic protozoa infection.

Bromodomain Proteins in *Tetrahymena thermophila* {#S4}
=================================================

There are several protein domains that selectively recognize and bind to acetylated Lysine (Kac) residues in histones ([@B71]) including PHD ([@B159]), YEATS ([@B87]) and the BRD that is the focus of this section. BRD-containing proteins are frequently dysregulated in cancer ([@B71]) and their expression has been demonstrated to be important for pathogenesis of several parasitic protozoa ([@B122]). Importantly, BRDs can be targeted by small-molecule inhibitors leading to the idea they can be targeted to control cancer and/or infection by parasitic protozoa ([@B75]; [@B81]; [@B67]; [@B100]). The polyploid MAC of Tt is massively enriched for acetylated chromatin which makes it a potentially useful system for discovering new BRD functions. A BLASTP-based survey of the Tt MAC genome revealed 14 potential BRD-containing gene products ([@B117]). Tt BRD proteins present one BRD per protein which is different to other described eukaryotes where BRD proteins often are present in tandem. The BRD is composed of four helices with the ZA and BC loops connecting helices αZ to αA, and αB to αC. The ZA and BC loops form a hydrophobic pocket that functions in Kac binding ([@B42]). The ZA and BC loops interact with residues flanking the Kac and are somewhat variable in sequence, reflecting the fact that different BRDs have distinct lysine acetylation sites in histones and non-histone proteins ([@B158]). A structure-based multiple sequence alignment of the 14 Tt BRDs ([Figure 3](#F3){ref-type="fig"}) shows conservation of BRD secondary structure. BRD-based Kac recognition involves hydrogen bond formation with a conserved Asparagine in the BC loop ([@B158]) which is conserved in all 14 Tt BRD proteins ([Figure 3](#F3){ref-type="fig"}). Phylogenetic analysis was performed using the 14 Tt BRD sequences ([@B117]) permitting their delineation into three main groups which is shown along with domain analysis of the respective full length protein in [Figure 4](#F4){ref-type="fig"}.

![Multiple sequence alignment of 14 Tt bromodomains (BRD). BRD sequence was extracted from the respective full length sequence using SMART. Clustal Omega was used to perform multiple sequence alignment (EMBL-EBI) and shaded using BoxShade (ExPASy) with absolutely conserved residues indicated by a black shade and conserved residues by a gray shade. The asterisk represents the highly conserved Asparagine (N) that makes contact with acetyl-lysine. Predicted secondary structure (JPRED) is shown along the top of the alignment.](fcell-08-00509-g003){#F3}

![Tetrahymena's 14 BRD proteins grouped based on phylogenetic analysis of BRD sequence. Figure adapted from [@B117].](fcell-08-00509-g004){#F4}

Group I BRD Proteins {#S4.SS1}
--------------------

Group I is composed of two proteins, the first a clear ortholog of **M**ixed-**L**ineage **L**eukemia **1** (MLL1), and BroP3 ([Figure 4](#F4){ref-type="fig"}). Mammalian MLL1 is a histone methyl-transferase (KMT2A) that positively regulates transcription by tri-methylation of H3K4 (H3K4me3) and is considered an ortholog of yeast Set1. Both mammalian MLL1 and yeast Set1 co-purify with a related protein complex, COMPASS ([@B124]). A previous study demonstrated that hyper-acetylated MAC-specific histone H3 tends to be rich in H3K4me3 ([@B133]). It seems possible that in Tt, highly expressed genes are rich in both modifications. Our sequence alignment indicates that the BRD of Tt MLL1 \[unlike that of human ([@B50])\] is predicted to have Kac-binding activity ([Figure 3](#F3){ref-type="fig"}) but its relatively divergent ZA loop sequence ([Figure 3](#F3){ref-type="fig"}) raises the possibility of a non-histone target. It is tempting to speculate that the BRD of MLL1 recruits histone methyltransferases (HMTs) to add the H3K4me3 modification to acetylated chromatin, promoting high levels of transcription. Interestingly, GroupII BRD protein Ibd1 co-purifies with another putative H3K4me3 HMT that does not itself possess a BRD (see below Section "Group II BRD Proteins"). BroP3, the other group I member, has a simple domain structure similar to Ibd1 (Section "Group II BRD Proteins") with a single N-terminal BRD.

Group II BRD Proteins {#S4.SS2}
---------------------

Group II is subdivided into two principal divisions ([Figure 4](#F4){ref-type="fig"}). Group IIA includes chromodomain helicase protein (CHD), with BRD situated between two N-terminal chromodomains, in addition to BroW1, possessing several WD-repeats and a C-terminal BRD. The MIC copy of the gene encoding BroW1 includes an IES ([@B66]). IES are rarely found in MIC sequence corresponding to coding sequence in the MAC due to their imprecise mechanism of elimination.

Group IIB includes BrAn1, in addition to several proteins related by their simple domain organization, BroP1, BroP2, BroP4, BroP5, and BroP6 ([Figure 4](#F4){ref-type="fig"}). BroP5 (also known as Ibd1 -**I**nteractive **B**R**D** protein **1**) is the best characterized BRD protein to date in Tt, initially identified as a member of the [Tt]{.ul} SWI/SNF CR complex via AP-MS of the conserved Snf5 subunit ([@B117]). Reciprocal AP-MS experiments revealed Ibd1 to also be a member of SWR, a SAGA-like and an HMT-containing complex ([@B117]). Incubation of recombinant Ibd1 with a histone post-translation modification peptide array ([@B117]) suggest that its BRD recognizes specific histone acetylation associated with the transcriptionally active MAC, H3K9/14ac, and H4K8ac ([@B29]; [@B133]). Indirect IF of Ibd1 showed localization to the MAC throughout the Tt life cycle consistent with a role for Ibd1-containing CR complexes in the regulation of transcription ([@B117]). Support for this hypothesis was provided by ChIP-Seq analysis of Ibd1 that revealed enrichment in the coding regions of highly expressed genes during growth leading to the proposal of the "pile-on" model where histone acetylation leads to Ibd1-dependent recruitment (or "piling on") of multiple CR activities that each individually contribute to high levels of transcription. To test the model, it will be important to assess the degree to which Ibd1 recruits each of the respective CR complex to the set of Ibd1-bound highly expressed genes. Also, although the model proposes an additive effect for each CR complex, it is possible that redundancies exist among them. The CR complexes hypothesized to be recruited by the Kac-binding of Ibd1 BRD include SWR, SWI/SNF, SAGA and a putative HMT.

The putative HMT that co-purifies with Ibd1 is uncharacterized, but sequence analysis indicates that it has homology to HMTs that have specificity for H3K4 or H3K36, both modifications associated with transcription. As discussed above for MLL, the association of Ibd1 and the HMT potentially could link transcription-associated histone acetylation to H3K4me3, providing a molecular mechanism behind the observation that hyper-acetylated MAC-specific histone H3 tends to be rich in H3K4me3 ([@B133]). The SWI/SNF complex is an ATP-dependent CR complex nucleated by SNF2/Brg1 ATPase subunit. The human Brd9 protein, similar to Ibd1 with only one BRD, was recently shown to be a member of human SWI/SNF complex ([@B145]). Unlike yeast and human cells, Tt Brg1/SNF2 does not possess a C-terminal BRD ([@B52]). The specificity of the Ibd1 BRD appears similar to that of the human and yeast Brg1/Snf2 subunit. The biochemical function of SWI/SNF is ATP-dependent remodeling of nucleosome structure by mobilizing nucleosomes by sliding and/or ejection of histone octamers ([@B120]). We speculate that the physical interaction of Ibd1 with SWI/SNF links histone acetylation to nucleosome sliding or ejection. Interestingly the association between Ibd1 and SWI/SNF appears much less stable during conjugation ([@B117]) indicating that the physical interaction between the two may be subject to regulation. The function of SWR-C in yeast (SRCAP in humans) is the deposition of Htz1/H2AZ ([@B80]; [@B115]). Previously the Allis lab demonstrated that Hv1, like Ibd1, localizes to the MAC of growing cells implicating Hv1 in transcription ([@B148]). Tt SWR-C was defined by the intersection of common proteins in Ibd1 and Swc4 AP-MS ([@B117]; [@B16]) with clear orthologs identified for Swr1, Yaf9, Rvb1, RvB2, Swc2, Swc4, and Swc5. AP-MS of Hv1 co-purified Swr1, Swc2, Arp5, and Rvb1 ([@B16]), consistent with Tt SWR-C function in the deposition of Hv1. In yeast, the NuA4 HAT acetylates H4 which recruits SWR via the BRD-containing Bdf1 subunit to deposit Htz1 ([@B47]; [@B13]). It is tempting to speculate that the Tt NuA4-like activity (discussed above) acetylates H4, proving a platform for Ibd1 recruitment and subsequent Hv1 deposition. Support for this model rests in the fact that Ibd1 appears to recognize H4K8ac ([@B117]) \[analogous to H4K7ac ([Figure 2B](#F2){ref-type="fig"})\] that is characteristic of NuA4 activity ([@B2]).

Group IIB proteins also include BroP6, BroP2, and BroP4, that are similar to BroP5/Ibd1 in that they are small (∼400 aa), with a single N-terminal BRD and no other recognizable domains. BroP6 in particular is highly similar to Ibd1/BroP5 in amino acid sequence and along with Ibd1 co-purifies in Hv1 AP-MS ([@B16]). INO80-C is a multi-subunit ATP-dependent CR complex ([@B110]) that possesses a histone-exchange activity that swaps nucleosomal H2A.Z/H2B with H2A/H2B ([@B105]) (in essence, the opposite of SWR-C). Several potential INO80-C subunits co-purified in AP-MS of Hv1-FZZ ([@B16]) including seven evolutionary conserved subunits present in INO80-C in yeast and human including INO80, Arp5, Arp8, and IES6 in addition to transcription factor YY1, a FHA domain protein and a ubiquitin hydrolase all present in human but not in yeast INO80-C. INO80-C has not been reported to possess a BRD protein in yeast but in human cells can be co-purified with Brd3 ([@B142]). Although a definitive physical link between Brop6 and Tt INO80-C awaits AP-MS of BroP6, it is tempting to speculate that while Ibd1 recruits SWR-C to deposit Hv1 into chromatin via acetylation of H4, BroP6 could regulate its removal via initial recognition of a different acetyl modification. If BroP6 is in fact found to regulate Hv1 removal, it will be important to determine the basis of Hv1 recognition. One possibility is that N-terminal Hv1 acetylation itself could be recognized by a BRD, although a previous genetic study argues that the essential function of Hv1 acetylation is mediated through a charge patch, not a *trans*-acting factor ([@B112]).

The only BRD reported to directly recognize acetyl-H2AZ is *T. brucei* BDF2 ([@B155]). The more likely possibility is that Hv1 is recognized within an Kac nucleosomal context, analogous to how human BRD2 recognizes H2AZ-containing nucleosomes containing acetyl-H4 ([@B44]). The Allis lab used an affinity purified polyclonal anti-Hv1 antibody to argue that Hv1 (unlike Ibd1) is be present in the meiotic MIC and may function in the pathway of MIC-specific genome-wide ncRNA transcription ([@B92]; [@B129]). Further work will be necessary to uncover the Ibd1-indepdent mechanism by which Hv1 is deposited in the meiotic MIC, but because of the apparent absence of Ibd1, it is unlikely to be related to histone acetylation.

The last Group IIB protein BrAn1 has a domain architecture consisting of a C-terminal BRD in combination with several N-terminal ankyrin repeats, resembling that of PfBDP1 in *P. falciparum*, the knockdown of which reduced ability to penetrate red blood cells with concomitant deregulation of invasion-associated genes ([@B77]). Interactome analysis of PfBDP1 indicates that it forms a core complex with an additional BRD protein, PfBDP2 ([@B69]) that appears to form a variety of sub-complexes with additional proteins including a PHD-domain containing protein ([@B69]) and a DNA-binding transcription factor AP2-I ([@B121]). The domain architecture of PfBDP1, and Tt BrAn1 is also conserved in the *T. gondii* ortholog (TGME49_263580) and appears to be unique to select protist lineages including Tt and apicomplexans ([@B75]). Functional characterization of Tt BrAn1 should contribute to the understanding of the apicomplexan version.

Group III BRD Proteins {#S4.SS3}
----------------------

Group III ([Figure 4](#F4){ref-type="fig"}) includes p55/Gcn5 and three proteins with a single BRD in combination with an Extra-Terminal (ET) Domain. Tt p55/Gcn5 possesses a C-terminal BRD, as does Gcn5 in other organisms. A two-step model was proposed by Taverna and colleagues for yeast Gcn5 which first acetylates H3K14 to provide a platform for binding by its BRD which stimulates its HAT activity on H3K18 ([@B32]). By analogy, the role of Tt Gcn5 BRD could be similar, stimulating Gcn5 activity after initial recruitment. In this case, the role of the Ibd1 BRD within SAGA would be to recruit SAGA to a region of chromatin perhaps acetylated by the NuA4 activity described above where it would acetylate H3, stimulating transcription. Bret-1 Bret-2 and Bret-3 are predicted to have an ET domain. They are similar in domain structure to the BET sub-family of human BRD proteins (BRD2, BRD3, BRD4, and the testis-specific BRDT) that harbor at their amino-termini two BRD followed by an ET domain that mediates protein-protein interactions. BET protein are intense subjects of research in human cells where they are implicated in cancer and are targets for molecules such as JQ1. Differently to human (and yeast) BET that possess two BRDs, Tt BETs only possess one BRD.

Histone Deacetylation in *Tetrahymena thermophila* {#S5}
==================================================

Histone deacetylases remove acetyl groups from lysine residues. Inhibitors that target HDACs have been used to target human diseases such as cancer ([@B72]; [@B84]). HDAC inhibitors are also being investigated in the treatment of parasitic diseases ([@B138]; [@B25]; [@B31]). Wiley and colleagues used a bioinformatic query of the Tt MAC genome ([@B126]) to predict the existence of 18 HDACs that are named THDs (***T****etrahymena* **H**istone **D**eacetylase) and classified according to their similarity to yeast HDACs Rpd3 (class I, 3 members including THD1), Hda1 (class II, 2 members including THD2), and Sir2 (class III, 11 members) with an additional 2 classified as HDAC-like, one of which (Thd5) is predicted to be an ortholog of HDAC11, the smallest HDAC and it is the sole member of HDAC IV family ([@B63]) implicated in mitosis and meiosis ([@B131]). Detailed molecular analysis has been performed on Tt HDACs, THD1 ([@B150], [@B149]; [@B106]), and THD2 ([@B126]).

The Class I HDAC THD1 {#S5.SS1}
---------------------

Class I THD1 was shown to be recruited to developing new macronuclei ([@B150]) and to be important for the integrity of macronuclear chromatin in logarithmically dividing cells ([@B149]). Cells knocked down for *THD1* contain higher amounts of MAC DNA, large extrusion bodies, and enlarged nucleoli ([@B149]). It was further shown ([@B106]) that MAC chromatin in *THD1* knockdowns failed to condense during starvation, which was correlated with aberrant hyper-phosphorylation of histone H1 and the overexpression of CDC2, encoding the major histone H1 kinase. Class I HDACs such as Rpd3 are conserved among eukaryotes and are frequently found in corepressor complexes, where they mediate repression by a variety of transcription factors. In humans, the SIN3/RPD3 complex that also contains RbAp46/48 in addition to several other proteins, is targeted to specific genes through protein-protein interactions between SIN3 and either DNA-binding repressors or corepressors ([@B85]; [@B79]). The metazoan DREAM complex is responsible for the transcriptional regulation of cell cycle-related genes ([@B116]). Recent findings hint at the existence of a DREAM complex in Tt ([@B160]). In human cells a Sin3B/HDAC complex robustly interacts with the DREAM complex in a cell-cycle-dependent manner ([@B17]). It remains to be determined whether THD1 exerts its phenotype though the Tt DREAM complex.

The Class II HDAC THD2 {#S5.SS2}
----------------------

Based on work in the 1980s, it was known that although transcription-related acetylation was never observed in the MIC, deposition-related patterns could be observed in the presence of HDAC inhibitors such as sodium butyrate ([@B6]) indicating that H3 and H4 assembled into MIC chromatin were subject to deposition-related acetylation but that was quickly removed post-assembly. GFP-tagging was used to demonstrate that the class II HDAC named Thd2 (Tt histone deacetylase 2) localized specifically to the MIC. A complete deletion of THD2 showed ectopic H3 and H4 acetylation in the MIC indicating that WT Thd2 function is to remove deposition related acetylation ([@B126]). Interestingly, the THD2 KO also displayed a defect in MIC morphology as well as the regulated proteolytic processing of its histone H3, specifically deficient in producing the fast form of H3 that in the MIC is phosphorylated on Ser10 ([@B9]; [@B11]), a mitotic PTM necessary for chromosome condensation and segregation ([@B146], [@B147]) suggesting that Thd2 functions upstream of the proteolytic cleavage and subsequent phosphorylation of Ser10 on histone H3. It will be interesting to determine if AP-MS of Thd2 can help identify the elusive protease responsible for this enigmatic process.

Class III HDAC {#S5.SS3}
--------------

Class III histone deacetylases, known as sirtuins, couple the deacetylation of lysine with the hydrolysis of NAD+ by transferring the acetyl group to the ADP-ribose moiety to form O-acetyl-ADP-ribose, releasing free nicotinamide ([@B38]). Nicotinamide can thus be used as an inhibitor of sirtuin class HDACs and was used to demonstrate a possible role for the sirtuins in meiotic prophase as well as the degradation of the parental MAC during conjugation ([@B125]).

More could be learned through the molecular analysis of Tt HDACs. The use of Trichostatin A, a selective inhibitor of class I and II HDACs, resulted in defects in the progression through meiosis and also affected the deletion of IESs ([@B46]). The identity of relevant HDAC(s) that function in these processes remains unknown.

Conclusion and Perspectives {#S6}
===========================

*Tetrahymena thermophila* offers a powerful model system with well-developed functional genomics with which to explore and understand the components of the histone acetylation cycle. The unique nuclear biology of Tt has been extremely useful in the past in the development of the histone acetylation field. Despite its efficacy the model has been underexplored. A complete understanding of the function and mechanism of the Tt histone acetylation cycle, in particular the role of histone acetylation in the regulation of H2AZ dynamics, should yield fundamental knowledge on the mechanism of transcription. In addition, the position of Tt on the evolutionary tree will permit insight into Alveolate-specific biology such as the composition of NuA4 and the identity of the protist H3K56-specific HAT.

Author Contributions {#S7}
====================

SW wrote the manuscript, edited and prepared [Figure 3](#F3){ref-type="fig"}. AS edited the manuscript and prepared [Figures 1](#F1){ref-type="fig"}, [4](#F4){ref-type="fig"}, SN-S and ND edited the manuscript. JF conceived, wrote, prepared [Figure 2](#F2){ref-type="fig"}, and edited the manuscript. All authors read and approved the final manuscript.

Conflict of Interest {#conf1}
====================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** Research in the Fillingham lab was supported by the Faculty of Science, Ryerson University, in addition to a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC).

[^1]: Edited by: Christoph Franz Kurat, Ludwig Maximilian University of Munich, Germany

[^2]: Reviewed by: Stephan Hamperl, Helmholtz Zentrum München, Germany; Yifan Liu, University of Michigan, United States

[^3]: ^†^Present address: Syed Nabeel-Shah, Donnelly Centre, University of Toronto, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada

[^4]: This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Cell and Developmental Biology
